Lisa Garrity, PharmD, SM, BCPS

Comparison of levetiracetam versus phenytoin/fosphenytoin for busulfan seizure prophylaxis at a pediatric institution. Hughes, K; Garrity, L; Nelson, AS; Lane, A; Teusink-Cross, A. Pediatric Transplantation. 2021; 25(4):e14026.

Refractory and Super-refractory Status Epilepticus. Samanta, D; Garrity, L; Arya, R. Indian Pediatrics. 2020; 57(3):239-253.

Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Glauser, T; Shinnar, S; Gloss, D; Alldredge, B; Arya, R; Bainbridge, J; Bare, M; Bleck, T; Dodson, WE; Garrity, L; Pellock, J; Riviello, J; Sloan, E; Treiman, DM. Epilepsy Currents. 2016; 16(1):48-61.

Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam. Garrity, LC; Turner, M; Standridge, SM. Pharmacotherapy. 2014; 34(7):e128-e132.

NMR structure of the flavin domain from soluble methane monooxygenase reductase from Methylococcus capsulatus (Bath). Chatwood, LL; Müller, J; Gross, JD; Wagner, G; Lippard, SJ. Biochemistry. 2004; 43(38):11983-11991.